{"analyses":[{"ciLowerLimit":"1.4","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"12.3","groupDescription":"Physical Functioning","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0139","paramType":"Mean Difference (Net)","paramValue":"6.9","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"3.2","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"19.5","groupDescription":"Role Functioning","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0065","paramType":"Mean Difference (Net)","paramValue":"11.4","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-6.9","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.3","groupDescription":"Emotional Functioning","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.3307","paramType":"Mean Difference (Net)","paramValue":"-2.3","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-1.4","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"7.0","groupDescription":"Cognitive Functioning","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.1904","paramType":"Mean Difference (Net)","paramValue":"2.8","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"0.7","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"16.1","groupDescription":"Social Functioning","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0336","paramType":"Mean Difference (Net)","paramValue":"8.4","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-1.7","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"10.3","groupDescription":"Global Health Status","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.1572","paramType":"Mean Difference (Net)","paramValue":"4.3","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-10.8","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.4","groupDescription":"Dyspnoea","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.1281","paramType":"Mean Difference (Net)","paramValue":"-4.7","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-8.7","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"5.2","groupDescription":"Insomnia","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.6207","paramType":"Mean Difference (Net)","paramValue":"-1.7","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-16.0","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"-1.4","groupDescription":"Appetite Loss","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0193","paramType":"Mean Difference (Net)","paramValue":"-8.7","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-4.4","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"7.3","groupDescription":"Constipation","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.6249","paramType":"Mean Difference (Net)","paramValue":"1.4","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-7.2","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.1","groupDescription":"Diarrhoea","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.1534","paramType":"Mean Difference (Net)","paramValue":"-3.0","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-9.7","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"4.7","groupDescription":"Financial Difficulties","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.4915","paramType":"Mean Difference (Net)","paramValue":"-2.5","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-10.8","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.0","groupDescription":"Fatigue","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.1789","paramType":"Mean Difference (Net)","paramValue":"-4.4","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-6.0","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.7","groupDescription":"Nausea and Vomiting","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.4578","paramType":"Mean Difference (Net)","paramValue":"-1.6","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"},{"ciLowerLimit":"-7.3","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"6.0","groupDescription":"Pain","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.8428","paramType":"Mean Difference (Net)","paramValue":"-0.7","statisticalComment":"Treatment, time, treatment-by-time interaction, and baseline included as covariate.","statisticalMethod":"Mixed Models Analysis"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.53","value":"0.48"},{"groupId":"OG001","spread":"3.55","value":"0.32"}]}],"title":"Physical Functioning C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.97","value":"3.15"},{"groupId":"OG001","spread":"7.70","value":"-13.33"}]}],"title":"Physical Functioning C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.84","value":"5.33"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Physical Functioning C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.51","value":"11.52"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Physical Functioning C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.94","value":"7.22"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Physical Functioning C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.03","value":"-3.38"},{"groupId":"OG001","spread":"2.67","value":"-8.17"}]}],"title":"Physical Functioning EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.79","value":"5.45"},{"groupId":"OG001","spread":"8.21","value":"-1.59"}]}],"title":"Role Functioning C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.19","value":"11.81"},{"groupId":"OG001","spread":"5.56","value":"-11.11"}]}],"title":"Role Functioning C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.47","value":"16.67"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Role Functioning C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.10","value":"12.88"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Role Functioning C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.42","value":"16.67"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Role Functioning C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.59","value":"1.32"},{"groupId":"OG001","spread":"4.09","value":"-12.37"}]}],"title":"Role Functioning EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.76","value":"5.21"},{"groupId":"OG001","spread":"6.77","value":"4.76"}]}],"title":"Emotional Functioning C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.85","value":"7.41"},{"groupId":"OG001","spread":"10.02","value":"-19.44"}]}],"title":"Emotional Functioning C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.63","value":"5.69"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Emotional Functioning C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.83","value":"6.82"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Emotional Functioning C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.27","value":"2.78"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Emotional Functioning C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.80","value":"-0.91"},{"groupId":"OG001","spread":"2.96","value":"4.35"}]}],"title":"Emotional Functioning EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.47","value":"4.05"},{"groupId":"OG001","spread":"3.98","value":"0.00"}]}],"title":"Cognitive Functioning C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.11","value":"5.79"},{"groupId":"OG001","spread":"14.70","value":"-5.56"}]}],"title":"Cognitive Functioning C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.86","value":"4.58"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"16.67"}]}],"title":"Cognitive Functioning C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.17","value":"0.76"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Cognitive Functioning C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.51","value":"-8.33"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Cognitive Functioning C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.82","value":"0.83"},{"groupId":"OG001","spread":"2.89","value":"0.54"}]}],"title":"Cognitive Functioning EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.46","value":"4.20"},{"groupId":"OG001","spread":"7.21","value":"-2.38"}]}],"title":"Social Functioning C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.25","value":"5.56"},{"groupId":"OG001","spread":"20.03","value":"-27.78"}]}],"title":"Social Functioning C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.95","value":"10.42"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Social Functioning C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.00","value":"12.88"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Social Functioning C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.03","value":"16.67"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Social Functioning C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.84","value":"1.82"},{"groupId":"OG001","spread":"4.78","value":"-2.15"}]}],"title":"Social Functioning EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.03","value":"3.98"},{"groupId":"OG001","spread":"4.62","value":"0.40"}]}],"title":"Global Health Status C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.15","value":"9.38"},{"groupId":"OG001","spread":"12.73","value":"-16.67"}]}],"title":"Global Health Status C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.69","value":"11.25"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"8.33"}]}],"title":"Global Health Status C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.68","value":"8.71"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Global Health Status C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.76","value":"0.69"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Global Health Status C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.83","value":"0.00"},{"groupId":"OG001","spread":"3.28","value":"-0.40"}]}],"title":"Global Health Status EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.72","value":"-5.41"},{"groupId":"OG001","spread":"6.47","value":"-7.94"}]}],"title":"Dyspnoea C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.24","value":"-7.41"},{"groupId":"OG001","spread":"11.11","value":"11.11"}]}],"title":"Dyspnoea C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.25","value":"-12.50"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Dyspnoea C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.55","value":"-3.03"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Dyspnoea C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.43","value":"-2.78"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Dyspnoea C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.09","value":"-2.31"},{"groupId":"OG001","spread":"3.95","value":"0.54"}]}],"title":"Dyspnoea EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.01","value":"-2.40"},{"groupId":"OG001","spread":"5.85","value":"1.59"}]}],"title":"Insomnia C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.38","value":"-9.26"},{"groupId":"OG001","spread":"19.25","value":"0.00"}]}],"title":"Insomnia C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.27","value":"-7.50"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Insomnia C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.55","value":"-4.55"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Insomnia C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.48","value":"-11.11"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Insomnia C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.09","value":"-2.31"},{"groupId":"OG001","spread":"3.91","value":"0.00"}]}],"title":"Insomnia EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.83","value":"-4.20"},{"groupId":"OG001","spread":"7.24","value":"3.17"}]}],"title":"Appetite Loss C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.31","value":"-8.33"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"title":"Appetite Loss C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.54","value":"-11.67"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Appetite Loss C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.80","value":"-6.06"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Appetite Loss C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.59","value":"2.78"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Appetite Loss C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.54","value":"-1.32"},{"groupId":"OG001","spread":"4.41","value":"11.83"}]}],"title":"Appetite Loss EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.47","value":"-1.21"},{"groupId":"OG001","spread":"5.14","value":"0.00"}]}],"title":"Constipation C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.44","value":"0.47"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"title":"Constipation C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.66","value":"-2.50"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Constipation C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.37","value":"0.00"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Constipation C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.56","value":"5.56"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Constipation C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.60","value":"2.64"},{"groupId":"OG001","spread":"2.71","value":"-0.54"}]}],"title":"Constipation EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.17","value":"-3.30"},{"groupId":"OG001","spread":"4.87","value":"-1.59"}]}],"title":"Diarrhoea C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.61","value":"-5.09"},{"groupId":"OG001","spread":"11.11","value":"-11.11"}]}],"title":"Diarrhoea C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.27","value":"-0.83"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Diarrhoea C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.68","value":"-9.52"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Diarrhoea C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.95","value":"-2.78"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Diarrhoea C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.89","value":"2.31"},{"groupId":"OG001","spread":"3.35","value":"3.76"}]}],"title":"Diarrhoea EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.99","value":"-1.80"},{"groupId":"OG001","spread":"8.72","value":"0.00"}]}],"title":"Financial Difficulties C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.24","value":"0.47"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"title":"Financial Difficulties C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.37","value":"-1.67"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"0.00"}]}],"title":"Financial Difficulties C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.74","value":"-3.03"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Financial Difficulties C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.75","value":"-5.56"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Financial Difficulties C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.09","value":"0.33"},{"groupId":"OG001","spread":"2.80","value":"2.19"}]}],"title":"Financial Difficulties EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.40","value":"-4.10"},{"groupId":"OG001","spread":"6.88","value":"5.82"}]}],"title":"Fatigue C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.02","value":"-8.33"},{"groupId":"OG001","spread":"6.42","value":"22.22"}]}],"title":"Fatigue C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.64","value":"-9.17"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"-11.11"}]}],"title":"Fatigue C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.61","value":"-7.32"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Fatigue C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.42","value":"0.00"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Fatigue C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.66","value":"-0.33"},{"groupId":"OG001","spread":"3.27","value":"5.73"}]}],"title":"Fatigue Eot"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.16","value":"0.15"},{"groupId":"OG001","spread":"2.69","value":"-0.79"}]}],"title":"Nausea and Vomiting C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.80","value":"-4.63"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"title":"Nausea and Vomiting C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.17","value":"-3.33"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"-16.67"}]}],"title":"Nausea and Vomiting C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.96","value":"2.27"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Nausea and Vomiting C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.90","value":"0.00"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Nausea and Vomiting C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.33","value":"-0.17"},{"groupId":"OG001","spread":"2.43","value":"3.49"}]}],"title":"Nausea and Vomiting EoT"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.71","value":"-8.86"},{"groupId":"OG001","spread":"7.68","value":"-7.14"}]}],"title":"Pain C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.73","value":"-8.56"},{"groupId":"OG001","spread":"14.70","value":"-5.56"}]}],"title":"Pain C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.81","value":"-4.17"},{"comment":"n=1","groupId":"OG001","spread":"NA","value":"-33.33"}]}],"title":"Pain C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.48","value":"0.76"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Pain C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.59","value":"-2.78"},{"comment":"n=0","groupId":"OG001","spread":"NA","value":"NA"}]}],"title":"Pain C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"2.88","value":"-1.98"},{"groupId":"OG001","spread":"3.75","value":"-7.26"}]}],"title":"Pain EoT"}],"denoms":[{"counts":[{"groupId":"OG000","value":"164"},{"groupId":"OG001","value":"162"}],"units":"Participants"}],"description":"This questionnaire comprised 30 questions within which are 9 multi-item scales \\& 6 single-item measures. There are 5 functional scales; physical, role, cognitive, emotional \\& social, 3 symptom scales; fatigue, pain, \\& nausea \\& vomiting, \\& a global health status/quality of life (QoL) scale. There are 5 single item measures assessing additional symptoms commonly reported by cancer patients (loss of appetite, insomnia, constipation, diarrhea, \\& dyspnea) \\& a single item concerning perceived financial impact of the disease. Most questions used a 4 point scale (1='not at all' to 4='very much'); 2 questions used a 7-point scale (1='very poor' to 7='excellent'). Scores were averaged \\& transformed to a scale ranging from 0 to 100; a higher score indicates a better level of functioning or greater degree of symptoms.","dispersionType":"Standard Error","groups":[{"description":"Participants were treated with inotuzumab ozogamicin at a starting dose of 1.8 mg/m\\^2 (according to body surface area) per cycle with a divided-dose regimen using 3 weekly administrations. Participants received 0.8 mg/m\\^2/cycle on Week 1 (Day 1), followed by 0.5 mg/m\\^2 on Week 2 (Day 8) and Week 3 (Day 15) of a 21-day cycle, and administered as an intravenous infusion over 60 minutes. For participants who achieved a CR or CRi, or to allow recovery from toxicity, the length of Cycle 1 could be extended up to 28 days (ie, 1 week treatment-free interval starting on Day 21). For participants who achieved CR or CRi, the inotuzumab ozogamicin dose administered on Week 1 was reduced to 0.5 mg/m\\^2 (for a total cycle dose of 1.5 mg/m\\^2/cycle) for Cycles 2 through 6 (maximum number of cycles permitted). For Cycles 2 through 6, the cycle length was 28 days for all participants (regardless of remission status).","id":"OG000","title":"Inotuzumab Ozogamicin"},{"description":"Participants received fludarabine, cytarabine, granulocyte-colony stimulating factor (FLAG), mitoxantrone + cytarabine (MXN/Ara-C), or high-dose cytarabine (HIDAC), according to the Investigator's choice.","id":"OG001","title":"Defined Investigator's Choice of Chemotherapy"}],"paramType":"MEAN","populationDescription":"ITT population. Although only 143 participants were treated in the Defined Investigator's Choice of Chemotherapy arm, all 162 randomized participants were included in the ITT population","reportingStatus":"POSTED","timeFrame":"Day 1 of each cycle prior to dosing and EoT","title":"Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core 30 (EORTC QLQ-C30) Score","type":"SECONDARY","unitOfMeasure":"Score on a scale"}